{"name": "Theraclone Sciences",
 "permalink": "theraclone-sciences",
 "crunchbase_url": "http://www.crunchbase.com/company/theraclone-sciences",
 "homepage_url": "http://www.theraclone-sciences.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2004,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@theraclone-sciences.com",
 "phone_number": "206-805-1600",
 "description": "",
 "created_at": "Fri Jul 23 03:17:12 UTC 2010",
 "updated_at": "Tue Mar 26 04:12:04 UTC 2013",
 "overview": "\u003Cp\u003ETheraclone Sciences is a Seattle-based discovery-stage biotech focused on the development of novel therapeutic antibodies for the treatment of infectious disease and inflammation. The company\u00e2\u20ac\u2122s technology harnesses the power of the human immune system to identify naturally evolved monoclonal antibodies from the blood cells of immunologically relevant human subjects. Recombinant human monoclonal antibodies can be rapidly obtained using our discovery platform and scaled for large-scale industrial production. Such antibody drug candidates may be uniquely important in combating disease and may have potential as therapeutic products that can be administered to a broad patient population. Theraclone is a privately held company with venture investment from ARCH Venture Partners, Canaan Partners, Healthcare Ventures, Amgen Ventures, MPM Capital, and Alexandria Real Estate Investment.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       32],
      "assets/images/resized/0009/4651/94651v1-max-150x150.jpg"],
     [[250,
       54],
      "assets/images/resized/0009/4651/94651v1-max-250x250.jpg"],
     [[305,
       67],
      "assets/images/resized/0009/4651/94651v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Executive Chairman and Acting President",
    "person":
     {"first_name": "Steven",
      "last_name": "Gillis",
      "permalink": "steven-gillis-2",
      "image": null}},
   {"is_past": false,
    "title": "Vice President, Chief Financial Officer",
    "person":
     {"first_name": "Russ",
      "last_name": "Hawkinson",
      "permalink": "russ-hawkinson",
      "image": null}},
   {"is_past": false,
    "title": "Board Member",
    "person":
     {"first_name": "Wende",
      "last_name": "Hutton",
      "permalink": "wende-hutton",
      "image":
       {"available_sizes":
         [[[127,
            150],
           "assets/images/resized/0026/0392/260392v1-max-150x150.jpg"],
          [[150,
            176],
           "assets/images/resized/0026/0392/260392v1-max-250x250.jpg"],
          [[150,
            176],
           "assets/images/resized/0026/0392/260392v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$26.1M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.xconomy.com/seattle/2010/03/19/theraclone-raises-1-5m/",
    "source_description": "Theraclone Raises $1.5M",
    "raised_amount": 1500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 3,
    "funded_day": 17,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Alexandria Real Estate Equities",
         "permalink": "alexandria-real-estate-equities",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0005/2582/52582v2-max-150x150.jpg"],
             [[235,
               82],
              "assets/images/resized/0005/2582/52582v2-max-250x250.jpg"],
             [[235,
               82],
              "assets/images/resized/0005/2582/52582v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Amgen Ventures",
         "permalink": "amgen-ventures",
         "image":
          {"available_sizes":
            [[[150,
               28],
              "assets/images/resized/0023/2414/232414v2-max-150x150.jpg"],
             [[250,
               47],
              "assets/images/resized/0023/2414/232414v2-max-250x250.jpg"],
             [[450,
               84],
              "assets/images/resized/0023/2414/232414v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "MPM Capital",
         "permalink": "mpm-capital",
         "image":
          {"available_sizes":
            [[[150,
               142],
              "assets/images/resized/0004/5561/45561v1-max-150x150.png"],
             [[180,
               171],
              "assets/images/resized/0004/5561/45561v1-max-250x250.png"],
             [[180,
               171],
              "assets/images/resized/0004/5561/45561v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "ARCH Venture Partners",
         "permalink": "arch-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               31],
              "assets/images/resized/0003/6165/36165v2-max-150x150.png"],
             [[250,
               51],
              "assets/images/resized/0003/6165/36165v2-max-250x250.png"],
             [[300,
               62],
              "assets/images/resized/0003/6165/36165v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Canaan Partners",
         "permalink": "canaan-partners-3",
         "image":
          {"available_sizes":
            [[[150,
               49],
              "assets/images/resized/0000/3958/3958v4-max-150x150.jpg"],
             [[250,
               82],
              "assets/images/resized/0000/3958/3958v4-max-250x250.jpg"],
             [[450,
               147],
              "assets/images/resized/0000/3958/3958v4-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HealthCare Ventures",
         "permalink": "healthcare-ventures",
         "image":
          {"available_sizes":
            [[[150,
               20],
              "assets/images/resized/0004/9268/49268v1-max-150x150.jpg"],
             [[250,
               34],
              "assets/images/resized/0004/9268/49268v1-max-250x250.jpg"],
             [[290,
               40],
              "assets/images/resized/0004/9268/49268v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://www.fiercebiotech.com/story/theraclone-makes-good-106m-vc-financing-plan/2011-09-08?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Theraclone makes good on $10.6M VC financing plan",
    "raised_amount": 10600000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 9,
    "funded_day": 8,
    "investments":
     []},
   {"round_code": "b",
    "source_url": "http://www.finsmes.com/2013/03/theraclone-sciences-closes-14m-series-debt-financing.html",
    "source_description": "Theraclone Sciences Closes $14M in Series B and Debt Financing",
    "raised_amount": 8000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 3,
    "funded_day": 25,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "ARCH Venture Partners",
         "permalink": "arch-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               31],
              "assets/images/resized/0003/6165/36165v2-max-150x150.png"],
             [[250,
               51],
              "assets/images/resized/0003/6165/36165v2-max-250x250.png"],
             [[300,
               62],
              "assets/images/resized/0003/6165/36165v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Canaan Partners",
         "permalink": "canaan-partners-3",
         "image":
          {"available_sizes":
            [[[150,
               49],
              "assets/images/resized/0000/3958/3958v4-max-150x150.jpg"],
             [[250,
               82],
              "assets/images/resized/0000/3958/3958v4-max-250x250.jpg"],
             [[450,
               147],
              "assets/images/resized/0000/3958/3958v4-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "MPM Capital",
         "permalink": "mpm-capital",
         "image":
          {"available_sizes":
            [[[150,
               142],
              "assets/images/resized/0004/5561/45561v1-max-150x150.png"],
             [[180,
               171],
              "assets/images/resized/0004/5561/45561v1-max-250x250.png"],
             [[180,
               171],
              "assets/images/resized/0004/5561/45561v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HealthCare Ventures",
         "permalink": "healthcare-ventures",
         "image":
          {"available_sizes":
            [[[150,
               20],
              "assets/images/resized/0004/9268/49268v1-max-150x150.jpg"],
             [[250,
               34],
              "assets/images/resized/0004/9268/49268v1-max-250x250.jpg"],
             [[290,
               40],
              "assets/images/resized/0004/9268/49268v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Alexandria Real Estate Equities",
         "permalink": "alexandria-real-estate-equities",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0005/2582/52582v2-max-150x150.jpg"],
             [[235,
               82],
              "assets/images/resized/0005/2582/52582v2-max-250x250.jpg"],
             [[235,
               82],
              "assets/images/resized/0005/2582/52582v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Amgen Ventures",
         "permalink": "amgen-ventures",
         "image":
          {"available_sizes":
            [[[150,
               28],
              "assets/images/resized/0023/2414/232414v2-max-150x150.jpg"],
             [[250,
               47],
              "assets/images/resized/0023/2414/232414v2-max-250x250.jpg"],
             [[450,
               84],
              "assets/images/resized/0023/2414/232414v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Versant Ventures",
         "permalink": "versant-ventures",
         "image":
          {"available_sizes":
            [[[150,
               30],
              "assets/images/resized/0004/6455/46455v2-max-150x150.jpg"],
             [[190,
               38],
              "assets/images/resized/0004/6455/46455v2-max-250x250.jpg"],
             [[190,
               38],
              "assets/images/resized/0004/6455/46455v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org": null,
       "person":
        {"first_name": "Zenyaku",
         "last_name": "Kogyo",
         "permalink": "zenyaku-kogyo",
         "image": null}}]},
   {"round_code": "debt_round",
    "source_url": "http://www.finsmes.com/2013/03/theraclone-sciences-closes-14m-series-debt-financing.html",
    "source_description": "Theraclone Sciences Closes $14M in Series B and Debt Financing",
    "raised_amount": 6000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 3,
    "funded_day": 25,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "MidCap Financial",
         "permalink": "midcap-financial",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0010/2688/102688v1-max-150x150.jpg"],
             [[176,
               46],
              "assets/images/resized/0010/2688/102688v1-max-250x250.jpg"],
             [[176,
               46],
              "assets/images/resized/0010/2688/102688v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Silicon Valley Bank",
         "permalink": "silicon-valley-bank-1",
         "image":
          {"available_sizes":
            [[[150,
               41],
              "assets/images/resized/0006/1420/61420v6-max-150x150.png"],
             [[250,
               69],
              "assets/images/resized/0006/1420/61420v6-max-250x250.png"],
             [[268,
               74],
              "assets/images/resized/0006/1420/61420v6-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Seattle Life Sciences Building",
    "address2": "1124 Columbia Street, Suite 300",
    "zip_code": "98104",
    "city": "Seattle",
    "state_code": "WA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "Theraclone Sciences Strikes $632M Research Deal With Pfizer",
    "stoned_year": 2011,
    "stoned_month": 1,
    "stoned_day": 19,
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29\u0026aid=DJFVLS0020110120e71k00004\u0026r=Rss\u0026s=DJFVLS",
    "source_text": "",
    "source_description": "Theraclone Sciences Strikes $632M Research Deal With Pfizer",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Theraclone Sciences",
      "permalink": "theraclone-sciences"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}